Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia

78 Citations (Scopus)

Abstract

Vaptans may correct hyponatraemia and mobilise ascites through an increased excretion of water. The effect on clinical outcomes is debated.
Original languageEnglish
JournalAlimentary Pharmacology and Therapeutics
Volume36
Issue number7
Pages (from-to)619-26
Number of pages8
ISSN0269-2813
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia'. Together they form a unique fingerprint.

Cite this